10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2020 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 18, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Revenues | |||
| Premiums | $ 104,109 | 94,173 | 85,421 |
| Product Revenue | 10,384 | 2,760 | 0 |
| Administrative fees and other revenue | 6,315 | 6,208 | 5,920 |
| Total operating revenue | 120,808 | 103,141 | 91,341 |
| Net investment income | 877 | 1,005 | 970 |
| Net realized gains (losses) on financial instruments | 182 | 67 | (206) |
| Total revenues | 121,867 | 104,213 | 92,105 |
| Expenses | |||
| Benefit expense | 88,045 | 81,786 | 71,895 |
| Cost of products sold | 8,953 | 1,992 | 0 |
| Selling, general and administrative expense | 17,450 | 13,364 | 14,020 |
| Interest expense | 784 | 746 | 753 |
| Amortization of other intangible assets | 361 | 338 | 358 |
| Loss on extinguishment of debt | 36 | 2 | 11 |
| Total expenses | 115,629 | 98,228 | 87,037 |
| Income before income tax expense | 6,238 | 5,985 | 5,068 |
| Income tax expense | 1,666 | 1,178 | 1,318 |
| Net income | 4,572 | 4,807 | 3,750 |
| Net income per share | |||
| Basic net income per share | 18.23 | 18.81 | 14.53 |
| Diluted net income per share | 17.98 | 18.47 | 14.19 |
| Dividends per share | 3.80 | 3.20 | 3.00 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2020 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 18, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Net income | $ 4,572 | 4,807 | 3,750 |
| Other comprehensive income (loss), net of tax: | |||
| Change in net unrealized gains/losses on investments | 428 | 680 | (418) |
| Change in non-credit component of impairment losses on investments net of tax | 0 | 0 | (2) |
| Change in net unrealized gains/losses on cash flow hedges | 12 | (16) | 37 |
| Change in net periodic pension and postretirement costs | (1) | 26 | (90) |
| Foreign currency translation adjustments | 7 | 0 | (1) |
| Other comprehensive income (loss) | 446 | 690 | (474) |
| Total comprehensive income | 5,018 | 5,497 | 3,276 |
| Consolidated Entities | |||
| Anthem, Inc. | |||
| Net income | 4,572 | 4,807 | 3,750 |
| Change in net unrealized gains/losses on investments | 428 | 680 | (418) |
| Change in non-credit component of impairment losses on investments net of tax | 0 | 0 | (2) |
| Change in net unrealized gains/losses on cash flow hedges | 12 | (16) | 37 |
| Change in net periodic pension and postretirement costs | (1) | 26 | (90) |
| Foreign currency translation adjustments | 7 | 0 | (1) |
| Other comprehensive income (loss) | 446 | 690 | (474) |
| Total comprehensive income | 5,018 | 5,497 | 3,276 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2020 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 18, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Operating activities | |||
| Net income | $ 4,572 | 4,807 | 3,750 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized (gains) losses on financial instruments | (182) | (67) | 206 |
| Depreciation and amortization | 1,154 | 1,133 | 1,132 |
| Deferred income taxes | (540) | 81 | 91 |
| Impairment of property and equipment | 198 | 0 | 0 |
| Share-based compensation | 283 | 294 | 226 |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (256) | (1,053) | (695) |
| Other invested assets | (32) | (48) | (1) |
| Other assets | (283) | (170) | (26) |
| Policy liabilities | 3,528 | 1,826 | (1,059) |
| Unearned income | 202 | 115 | (36) |
| Accounts payable and other liabilities | 1,978 | (445) | 97 |
| Income taxes | 72 | (325) | 323 |
| Other, net | (6) | (87) | (181) |
| Net cash provided by operating activities | 10,688 | 6,061 | 3,827 |
| Investing activities | |||
| Purchases of investments | (19,492) | (22,954) | (9,671) |
| Proceeds from sale of investments | 11,318 | 18,598 | 9,662 |
| Maturities, calls and redemptions from investments | 4,741 | 2,437 | 1,938 |
| Changes in securities lending collateral | (849) | 254 | (149) |
| Purchases of subsidiaries, net of cash acquired | (1,976) | 0 | (1,760) |
| Purchases of property and equipment | (1,021) | (1,077) | (1,208) |
| Other, net | (45) | (50) | (71) |
| Net cash used in investing activities | (7,324) | (2,792) | (1,259) |
| Financing activities | |||
| Net repayments of commercial paper borrowings | (150) | (297) | (107) |
| Proceeds from long-term borrowings | 2,484 | 2,473 | 835 |
| Repayments of long-term borrowings | (1,932) | (1,123) | (1,684) |
| Proceeds from short-term borrowings | 970 | 7,590 | 9,120 |
| Repayments of short-term borrowings | (1,670) | (8,035) | (9,250) |
| Changes in securities lending payable | 849 | (254) | 150 |
| Proceeds from issuance of common stock under Equity Units stock purchase agreements | 0 | 0 | 1,250 |
| Repurchase and retirement of common stock | (2,700) | (1,701) | (1,685) |
| Cash dividends | (954) | (818) | (776) |
| Proceeds from issuance of common stock under employee stock plans | 176 | 187 | 173 |
| Taxes paid through withholding of common stock under employee stock plans | (128) | (84) | (81) |
| Other, net | 488 | (204) | (186) |
| Net cash used in financing activities | (2,567) | (2,266) | (2,241) |
| Effect of foreign exchange rates on cash and cash equivalents | 7 | 0 | (2) |
| Change in cash and cash equivalents | 804 | 1,003 | 325 |
| Cash and cash equivalents at beginning of year | 4,937 | 3,934 | |
| Cash and cash equivalents at end of year | 5,741 | 4,937 | 3,934 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELEVANCE HEALTH, INC. | ||
Ticker: ELV Fiscal Year: 2020 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2020 10-K (Filed: Feb 18, 2021) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2020 | Dec 31, 2019 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 5,741 | 4,937 |
| Fixed maturity securities, current (amortized cost of $22,222 and $19,021; allowance for credit losses of $7 and $0) | 23,433 | 19,676 |
| Equity securities, current | 1,559 | 1,009 |
| Premium receivables | 5,279 | 5,014 |
| Self-funded receivables | 2,849 | 2,570 |
| Other receivables | 2,830 | 2,807 |
| Other current assets | 4,060 | 3,020 |
| Total current assets | 45,751 | 39,033 |
| Fixed maturity securities (amortized cost of $532 and $487; allowance for credit losses of $0 and $0) | 562 | 505 |
| Other invested assets, long-term | 4,285 | 4,258 |
| Property and equipment, net | 3,483 | 3,133 |
| Goodwill | 21,691 | 20,500 |
| Other intangible assets | 9,405 | 8,674 |
| Other noncurrent assets | 1,438 | 1,350 |
| Total assets | 86,615 | 77,453 |
| Liabilities and shareholders' equity | ||
| Medical claims payable | 11,359 | 8,842 |
| Other policyholder liabilities | 4,590 | 3,050 |
| Unearned income | 1,259 | 1,017 |
| Accounts payable and accrued expenses | 5,493 | 4,198 |
| Short-term borrowings | 0 | 700 |
| Current portion of long-term debt | 700 | 1,598 |
| Other current liabilities | 6,052 | 4,127 |
| Total current liabilities | 29,453 | 23,532 |
| Long-term debt, less current portion | 19,335 | 17,787 |
| Reserves for future policy benefits, noncurrent | 794 | 759 |
| Deferred tax liabilities, net | 2,019 | 2,227 |
| Other noncurrent liabilities | 1,815 | 1,420 |
| Total liabilities | 53,416 | 45,725 |
| Commitments and contingenciesNote 14 | ||
| Shareholders' equity | ||
| Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none | 0 | 0 |
| Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 245,401,430 and 252,922,161 | 3 | 3 |
| Additional paid-in capital | 9,244 | 9,448 |
| Retained earnings | 23,802 | 22,573 |
| Accumulated other comprehensive income (loss) | 150 | (296) |
| Total shareholders' equity | 33,199 | 31,728 |
| Total liabilities and shareholders' equity | 86,615 | 77,453 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |